{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:22:35Z","timestamp":1782699755621,"version":"3.54.5"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118454","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T18:48:22Z","timestamp":1425408502000},"page":"e0118454","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?"],"prefix":"10.1371","volume":"10","author":[{"given":"Aukje C.","family":"Bos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"van Holsbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"de Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"van Westreenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hettie M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim G.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm A. W. M.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1517\/14656566.2013.790366","article-title":"Inhaled antibiotics for the treatment of chronic bronchopulmonary pseudomonas aeruginosa infection in cystic fibrosis: Systematic review of randomised controlled trials","volume":"14","author":"L Maiz","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"21","key":"ref2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1056\/NEJMe1303487","article-title":"Identifying the origins of cystic fibrosis lung disease","volume":"368","author":"SD Davis","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jamp.2011.0923","article-title":"Cystic fibrosis: The role of the small airways","volume":"25","author":"F Ratjen","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ppul.21154","article-title":"Cystic fibrosis lung disease starts in the small airways: Can we treat it more effectively?","volume":"45","author":"HA Tiddens","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2012.12.042","article-title":"Distribution of early structural lung changes due to cystic fibrosis detected with chest computed tomography","volume":"163","author":"LS Mott","year":"2013","journal-title":"J Pediatr"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/thx.2008.110908","article-title":"The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease","volume":"64","author":"M Loeve","year":"2009","journal-title":"Thorax"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.2000.15d18.x","article-title":"Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs","volume":"15","author":"HA Tiddens","year":"2000","journal-title":"Eur Respir J"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/thx.2006.062190","article-title":"A morphometric study of mucins and small airway plugging in cystic fibrosis","volume":"62","author":"PR Burgel","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1164\/ajrccm\/140.6.1650","article-title":"Immunohistopathologic localization of pseudomonas aeruginosa in lungs from patients with cystic fibrosis. implications for the pathogenesis of progressive lung deterioration","volume":"140","author":"RS Baltimore","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/jam.2007.0603","article-title":"Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics","volume":"20","author":"MA Hasan","year":"2007","journal-title":"J Aerosol Med"},{"issue":"15","key":"ref11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1517\/14656566.2013.831070","article-title":"Inhaled aztreonam lysine: An evidence-based review","volume":"14","author":"D Hutchinson","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"Supplement 1","key":"ref12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annhyg\/32.inhaled_particles_VI.11","article-title":"Tracheobronchial deposition predictions for infants, children and adolescents","volume":"32","author":"RF Phalen","year":"1988","journal-title":"Ann occup Hyg [Inhaled Particles VI]"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/CMR.00022-14","article-title":"Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients","volume":"27","author":"A Dalhoff","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jamp.2011.0916","article-title":"Aerosol deposition in health and disease","volume":"25","author":"C Darquenne","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.20860","article-title":"The science of aerosol delivery in cystic fibrosis","volume":"43","author":"DE Geller","year":"2008","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.medengphy.2007.11.002","article-title":"Flow analyses in the lower airways: Patient-specific model and boundary conditions","volume":"30","author":"JW De Backer","year":"2008","journal-title":"Med Eng Phys"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1148\/radiol.10100322","article-title":"Validation of computational fluid dynamics in CT-based airway models with SPECT\/CT","volume":"257","author":"JW De Backer","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08958378.2011.644351","article-title":"A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: Effect of upper airway morphology and comparison with in vivo data","volume":"24","author":"S Vinchurkar","year":"2012","journal-title":"Inhal Toxicol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jbiomech.2007.07.009","article-title":"Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation","volume":"41","author":"JW De Backer","year":"2008","journal-title":"J Biomech"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.00072511","article-title":"The acute effect of budesonide\/formoterol in COPD: A multi-slice computed tomography and lung function study","volume":"40","author":"LA De Backer","year":"2012","journal-title":"Eur Respir J"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000347120","article-title":"Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone\/formoterol","volume":"86","author":"W Vos","year":"2013","journal-title":"Respiration"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","article-title":"Reference ranges for spirometry across all ages: A new approach","volume":"177","author":"S Stanojevic","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"ref23","first-page":"520","article-title":"A brief description of methods for studying pulmonary function in children and adolescents","volume":"47","author":"A Zapletal","year":"1992","journal-title":"Cesk Pediatr"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2011.954","article-title":"Effect of bronchoalveolar lavage-directed therapy on pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial","volume":"306","author":"CE Wainwright","year":"2011","journal-title":"JAMA"},{"key":"ref25","article-title":"Handleiding bij het meten en wegen van kinderen en het invullen van groeidiagrammen","author":"H Talma","year":"2010"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/adc.2004.068718","article-title":"Age related reference ranges for respiration rate and heart rate from 4 to 16 years","volume":"90","author":"LA Wallis","year":"2005","journal-title":"Arch Dis Child"},{"issue":"42","key":"ref27","doi-asserted-by":"crossref","first-page":"35751","DOI":"10.1074\/jbc.M505832200","article-title":"Normal and cystic fibrosis airway surface liquid homeostasis. the effects of phasic shear stress and viral infections","volume":"280","author":"R Tarran","year":"2005","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.physiol.68.072304.112754","article-title":"Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress","volume":"68","author":"R Tarran","year":"2006","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14656566.2010.482102","article-title":"Optimal airway antimicrobial therapy for cystic fibrosis: The role of inhaled aztreonam lysine","volume":"11","author":"JS Elborn","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ppul.20429","article-title":"Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis","volume":"41","author":"RL Gibson","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"8476","key":"ref31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"JM Bland","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/lam.12032","article-title":"Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen pseudomonas aeruginosa","volume":"56","author":"CG Nair","year":"2013","journal-title":"Lett Appl Microbiol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1183\/09031936.00006211","article-title":"Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation","volume":"38","author":"EM Bakker","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2125.2001.01304.x","article-title":"Methods to identify drug deposition in the lungs following inhalation","volume":"51","author":"H Chrystyn","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2010.08.019","article-title":"Lung deposition of inhaled tobramycin with eFlow rapid\/LC plus jet nebuliser in healthy and cystic fibrosis subjects","volume":"10","author":"W Lenney","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jamp.2011.0897","article-title":"Using MRI to measure aerosol deposition","volume":"25","author":"RB Thompson","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1183\/09031936.00051512","article-title":"Chest computed tomography; a validated surrogate endpoint of cystic fibrosis lung disease?","volume":"42","author":"M Loeve","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03256617","article-title":"Delivering antibacterials to the lungs: Considerations for optimizing outcomes","volume":"1","author":"M Cazzola","year":"2002","journal-title":"Am J Respir Med"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03256610","article-title":"Intrapulmonary pharmacokinetics of antibacterial agents: Implications for therapeutics","volume":"1","author":"LM Chiu","year":"2002","journal-title":"Am J Respir Med"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.200301-111OC","article-title":"Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid","volume":"168","author":"K Yamazaki","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway pseudomonas infections of cystic fibrosis patients","volume":"109","author":"D Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11592900-000000000-00000","article-title":"Penetration of anti-infective agents into pulmonary epithelial lining fluid: Focus on antifungal, antitubercular and miscellaneous anti-infective agents","volume":"50","author":"KA Rodvold","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"SH Donaldson","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0924-8579(02)00031-6","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs","volume":"19","author":"JW Mouton","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: An update","volume":"55","author":"JW Mouton","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.00248-09","article-title":"In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis","volume":"54","author":"P King","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ppul.21301","article-title":"An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis","volume":"45","author":"CM Oermann","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis","volume":"135","author":"GZ Retsch-Bogart","year":"2009","journal-title":"Chest"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.01393-12","article-title":"High beta-lactamase levels change the pharmacodynamics of beta-lactam antibiotics in pseudomonas aeruginosa biofilms","volume":"57","author":"W Hengzhuang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"KS McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:54:35Z","timestamp":1717775675000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118454"}},"subtitle":[],"editor":[{"given":"Philipp","family":"Latzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118454","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]}}}